QMMM Holdings Limited Ordinary Shares (QMMM) has had the highest return since July 25, 2025 by a mid-cap US stock, returning 5,024.5%.
| ASSET | % RETURN |
|---|---|
QMMM Holdings Limited Ordinary Shares (QMMM) | 5,024.46% |
AXT (AXTI) | 2,283.75% |
Erasca (ERAS) | 964.94% |
Celcuity LLC (CELC) | 664.61% |
Sellas Life Sciences (SLS) | 593.48% |
Alumis (ALMS) | 587.14% |
Oruka Therapeutics (ORKA) | 509.05% |
Nanobiotix (NBTX) | 491.88% |
Praxis Precision Medicines (PRAX) | 457.64% |
Spyre Therapeutics (SYRE) | 455.34% |
Relay Therapeutics (RLAY) | 437.77% |
MaxLinear (MXL) | 427.75% |
Kodiak Sciences (KOD) | 399.52% |
Bandwidth (BAND) | 395.6% |
Definium Therapeutics (DFTX) | 387.27% |
Ichor (ICHR) | 374.46% |
MBX Biosciences, Inc Common Stock (MBX) | 372.89% |
Tango Therapeutics (TNGX) | 360.83% |
Applied Opt (AAOI) | 354.07% |
Dianthus Therapeutics (DNTH) | 349.36% |
Ultra Clean (UCTT) | 348.78% |
ChronoScale (CHRN) | 339.08% |
ChipMOS Technologies (IMOS) | 328.72% |
Liquidia Technologies (LQDA) | 315.63% |
Almonty Industries Inc Common Shares (ALM) | 312.16% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.